Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02015741

Comparability of Bispectral Index and NeuroSENSE in Aged Patients

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

The assessment of anesthesia depth was based, until recently, on the evolution of hemodynamic parameters. Nowadays it can be evaluated by several monitoring methods, derived from electroencephalogram analysis, namely the Bispectral Index (Aspect Medical Systems, Newton, USA). A new modality is currently under development: the NeuroSENSE (Cleveland Medical Devices Inc., Cleveland, OH 44103, USA). Use of such devices is discussed in aged patients. The purpose of this study is to compare Bispectral Index and NeuroSENSE during awake periods and during natural sleep.

Conditions

Interventions

TypeNameDescription
DEVICEEEG monitoring with Bispectral Index and NeuroSENSE
BEHAVIORALClinical observationPatients will be observed during awake periods and during natural sleep.

Timeline

Start date
2013-11-01
Primary completion
2015-11-01
Completion
2015-12-01
First posted
2013-12-19
Last updated
2016-10-31

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02015741. Inclusion in this directory is not an endorsement.